Edwards Lifesciences (EW) stock and Medtronic (MDT) stock gain as Boston Scientific (BSX) halts sales of ACURATE heart valves ...

This was the stock's fourth consecutive day of gains.

A Relative Strength Rating upgrade for Edwards Lifesciences shows improving technical performance. Will it continue?

Edwards Lifesciences (NYSE:EW) saw its shares rise by 3% following news that competitor Boston Scientific (NYSE:BSX) is ...

This was the stock's second consecutive day of gains.

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR ...

Abbott said the Tendyne system addresses a significant unmet need in cardiac care, providing an option for patients ineligible for open heart surgery and whose valves cannot be successfully repaired ...

Investors responded positively to the news, boosting Edwards Lifesciences’ stock during the trading session. The company, which is a leading player in the heart valve market, may now face less ...

St. Luke’s Heart Team pioneers first EVOQUE tricuspid valve replacement in the region, offering new hope for patients with ...

Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS).

PARIS, May 22, 2025--Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS) presented as a late-breaking clinical trial at EuroPCR 2025 ...

New research by Edwards Lifesciences has demonstrated that early intervention for severe aortic stenosis (AS) before symptoms ...